What Happened to the Firewall?
Executive Summary
Merck's obvious and exclusive success with Medco has other drug-company owned PBMs crying foul. But now a lawsuit against Medco questions the length to which the PBM will go to help its pharmaceutical parent. And it comes at a time when PBMs, in general, seem to be moving away from formulary policies that restrict patient choice.